The role of surgery in older patients with T1-2N0M0 small cell lung cancer: A propensity score matching analysis

被引:3
|
作者
Ning, Jing [1 ]
Ge, Tao [2 ]
Zhu, Shuncang [2 ]
Han, Yingli [1 ]
Ruan, Suhong [1 ]
Ma, Yuchen [1 ]
Liu, Rentao [1 ]
机构
[1] Nanjing Med Univ, Affiliated Suzhou Hosp, Suzhou Municipal Hosp, Dept Oncol, Suzhou, Peoples R China
[2] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Thorac Surg, Shanghai, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词
small cell lung cancer; older patients; prognosis; propensity score matching; surgery; STAGE-I; THORACIC RADIOTHERAPY; PROGNOSTIC-FACTORS; AMERICAN-COLLEGE; CLINICAL-TRIALS; COMORBIDITY; RESECTION; SURVIVAL; OUTCOMES; AGE;
D O I
10.3389/fonc.2022.958187
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundSurgical resection could improve the survival of patients with early-stage small cell lung cancer (SCLC). However, there is a lack of dedicated studies concentrating on surgical treatment in older patients with T1-2N0M0 SCLC. Thus, we performed this population-based study to investigate whether older patients with T1-2N0M0 SCLC could benefit from surgery. MethodsWe collected the data of patients with SCLC between 2000 and 2015 from the Surveillance, Epidemiology, and End Results Program database. Older patients (>= 65 years) with T1-2N0M0 SCLC were included, and we converted the staging information into those of the eighth edition. The propensity score matching (PSM) was used to balance the distribution of clinical characteristics between surgery and no-surgery groups. ResultsBefore PSM, the distribution proportions of clinical characteristics in 1,229 patients were unbalanced. The Kaplan-Meier curves of overall survival (OS) and cancer-specific survival (CSS) showed that the patients in the surgery group were better than those in the non-surgery group (all P < 0.001). After 1:2 PSM, the distribution proportions of clinical characteristics in 683 patients were balanced (all P > 0.05). The OS and CSS of patients in the surgery group were still better than that of patients in the no-surgery group (all P < 0.001), and subgroup analysis showed that the surgery was a protective factor for OS and CSS in all clinical characteristics subgroups (almost P < 0.001). The multivariate Cox analysis further confirmed this result (OS: HR, 0.33; 95% CI, 0.27-0.39; P < 0.001; CSS: HR, 0.29; 95% CI, 0.23-0.36; P < 0.001). The result of subgroup analysis based on age, T stage, and adjuvant therapy showed that surgery was related to better OS and CSS compared with non-surgery group (almost P < 0.001) and that lobectomy exhibited the longer survival than sublobectomy. Age, sex, and race were the independent prognostic factors for OS in patients undergoing surgery, whereas only the factor of age affects the CSS in patients with surgery. ConclusionsOlder patients with T1-2N0M0 SCLC can benefit significantly from surgical treatment, and lobectomy provides better prognosis than sublobectomy.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Role of Pneumonectomy in T1-4N2M0 Non-Small Cell Lung Cancer: A Propensity Score Matching Analysis
    Wang, Suyu
    Wang, Qing
    Zhu, Wanli
    Wei, Juan
    Feng, Di
    Lv, Xin
    Liu, Meiyun
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [2] Wedge resection before lobectomy for patients with T1N0M0 non-small cell lung cancer: a propensity score matching analysis
    Zeng, Yuan
    Huang, Ying
    Fu, Junhui
    Xu, Ke
    Liang, Wenhua
    Cui, Fei
    Hao, Zhexue
    Li, Xukai
    Xing, Tuo
    He, Jianxing
    Liu, Jun
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (09)
  • [3] Radiotherapy vs surgery for T1-2N0M0 laryngeal squamous cell carcinoma: A population-based and propensity score matching study
    Zhan, Cheng
    Yang, Xiaodong
    Song, Xinmao
    Yan, Li
    [J]. CANCER MEDICINE, 2018, 7 (07): : 2837 - 2847
  • [4] Stereotactic ablative radiotherapy for inoperable T1-2N0M0 small-cell lung cancer
    Tang, Hui
    Liu, Wei
    Huang, Kaiming
    [J]. THORACIC CANCER, 2022, 13 (07) : 1100 - 1101
  • [5] Comparison of the outcomes of sublobar resection and stereotactic body radiotherapy for stage T1-2N0M0 non-small cell lung cancer with tumor size ≤ 5 cm: a propensity score matching analysis
    Dong, Baiqiang
    Zhu, Xuan
    Jin, Jianan
    Chen, Yuanyuan
    Ying, Hangjie
    Chen, Yamei
    Lu, Fangxiao
    Shen, Wei
    Wang, Jin
    Chen, Ming
    [J]. JOURNAL OF THORACIC DISEASE, 2020, 12 (10) : 5934 - 5944
  • [6] Stereotactic ablative radiotherapy in T1-2N0M0 small cell lung cancer: A systematic review and meta-analysis
    Safavi, Amir H.
    Mak, David Y.
    Boldt, R. Gabriel
    Chen, Hanbo
    Louie, Alexander, V
    [J]. LUNG CANCER, 2021, 160 : 179 - 186
  • [7] Stereotactic Ablative Radiotherapy in T1-2N0M0 Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Safavi, A. H.
    Mak, D.
    Boldt, G.
    Chen, H.
    Louie, A. V.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E106 - E107
  • [8] STEREOTACTIC ABLATIVE RADIOTHERAPY IN T1-2N0M0 SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Safavi, Amir H.
    Mak, David Y. P.
    Boldt, R. Gabriel
    Chen, Hanbo
    Louie, Alexander V.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2020, 150 : S85 - S85
  • [9] Treatment Patterns and Survival Outcomes in Patients With Stage T1-2N0M0 Small Cell Lung Cancer Undergoing Surgery: A Retrospective Cohort Study
    Huang, Jiang Qiong
    Liang, Huan Wei
    Liu, Yang
    Chen, Long
    Pei, Su
    Yu, Bin Bin
    Huang, Wei
    Pan, Xin Bin
    [J]. WORLD JOURNAL OF ONCOLOGY, 2024, 15 (01) : 126 - 135
  • [10] PROGNOSTIC FACTORS FOR THE PATIENTS WITH T1-2N0M0 BREAST CANCER
    Cetintas, S. Kahraman
    Ozkan, L.
    Kurt, S.
    Kurt, M.
    Kartal, C.
    Tasdelen, I.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S201 - S202